Di Carlo Mariano N, Said Matilde, Ling Haiyun, Valverde Carlos A, De Giusti Verónica C, Sommese Leandro, Palomeque Julieta, Aiello Ernesto A, Skapura Darlene G, Rinaldi Gustavo, Respress Jonathan L, Brown Joan Heller, Wehrens Xander H T, Salas Margarita A, Mattiazzi Alicia
Centro de Investigaciones Cardiovasculares, CCT, La Plata, Facultad de Ciencias Médicas, 60 y 120, 1900 La Plata, Argentina.
Department of Pharmacology, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0636, USA.
J Mol Cell Cardiol. 2014 Sep;74:274-83. doi: 10.1016/j.yjmcc.2014.06.004. Epub 2014 Jun 17.
Ca(2+)-calmodulin kinase II (CaMKII) activation is deleterious in cardiac ischemia/reperfusion (I/R). Moreover, inhibition of CaMKII-dependent phosphorylations at the sarcoplasmic reticulum (SR) prevents CaMKII-induced I/R damage. However, the downstream targets of CaMKII at the SR level, responsible for this detrimental effect, remain unclear. In the present study we aimed to dissect the role of the two main substrates of CaMKII at the SR level, phospholamban (PLN) and ryanodine receptors (RyR2), in CaMKII-dependent I/R injury. In mouse hearts subjected to global I/R (45/120min), phosphorylation of the primary CaMKII sites, S2814 on cardiac RyR2 and of T17 on PLN, significantly increased at the onset of reperfusion whereas PKA-dependent phosphorylation of RyR2 and PLN did not change. Similar results were obtained in vivo, in mice subjected to regional myocardial I/R (1/24h). Knock-in mice with an inactivated serine 2814 phosphorylation site on RyR2 (S2814A) significantly improved post-ischemic mechanical recovery, reduced infarct size and decreased apoptosis. Conversely, knock-in mice, in which CaMKII site of RyR2 is constitutively activated (S2814D), significantly increased infarct size and exacerbated apoptosis. In S2814A and S2814D mice subjected to regional myocardial ischemia, infarct size was also decreased and increased respectively. Transgenic mice with double-mutant non-phosphorylatable PLN (S16A/T17A) in the PLN knockout background (PLNDM) also showed significantly increased post-ischemic cardiac damage. This effect cannot be attributed to PKA-dependent PLN phosphorylation and was not due to the enhanced L-type Ca(2+) current, present in these mice. Our results reveal a major role for the phosphorylation of S2814 site on RyR2 in CaMKII-dependent I/R cardiac damage. In contrast, they showed that CaMKII-dependent increase in PLN phosphorylation during reperfusion opposes rather than contributes to I/R damage.
钙调蛋白激酶II(CaMKII)的激活在心脏缺血/再灌注(I/R)过程中具有有害作用。此外,抑制肌浆网(SR)处CaMKII依赖性磷酸化可预防CaMKII诱导的I/R损伤。然而,在SR水平上,导致这种有害作用的CaMKII下游靶点仍不清楚。在本研究中,我们旨在剖析CaMKII在SR水平上的两个主要底物——受磷蛋白(PLN)和兰尼碱受体(RyR2)在CaMKII依赖性I/R损伤中的作用。在经历全心I/R(45/120分钟)的小鼠心脏中,再灌注开始时,心脏RyR2上的主要CaMKII位点S2814以及PLN上的T17的磷酸化显著增加,而RyR2和PLN的蛋白激酶A(PKA)依赖性磷酸化没有变化。在经历局部心肌I/R(1/24小时)的小鼠体内也获得了类似结果。RyR2上丝氨酸2814磷酸化位点失活的敲入小鼠(S2814A)显著改善了缺血后机械功能恢复,减小了梗死面积并减少了细胞凋亡。相反,RyR2的CaMKII位点持续激活的敲入小鼠(S2814D)显著增加了梗死面积并加剧了细胞凋亡。在经历局部心肌缺血的S2814A和S2814D小鼠中,梗死面积也分别减小和增加。在PLN基因敲除背景下具有双突变不可磷酸化PLN(S16A/T17A)的转基因小鼠(PLNDM)也显示出缺血后心脏损伤显著增加。这种效应不能归因于PKA依赖性PLN磷酸化,也不是由于这些小鼠中存在的增强的L型钙电流。我们的结果揭示了RyR2上S2814位点的磷酸化在CaMKII依赖性I/R心脏损伤中起主要作用。相反,结果表明再灌注期间CaMKII依赖性PLN磷酸化增加对I/R损伤起对抗作用而非促进作用。